Recent News for NVIV - InVivo Therapeutics Holdings Corp.

Date Title
Apr 17 InVivo Therapeutics Announces Closing of $3.0 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
Apr 16 InVivo Therapeutics launches $3M direct offering; shares down 8% premarket
Apr 15 InVivo Therapeutics Announces $3.0 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
Mar 11 InVivo Therapeutics Announces Closing of $7.0 Million Public Offering
Mar 10 The Daily Biotech Pulse: Mesoblast To Test Candidate On Coronavirus Symptoms, Proxy Battle Ahead For Rockwell Medical, Glaukos to Join S&P SmallCap 600 Index
Mar 9 100 Biggest Movers From Friday
Mar 6 Mid-Afternoon Market Update: Dow Falls 600 Points; American Outdoor Brands Shares Slide On Downbeat Results
Mar 6 Mid-Morning Market Update: Markets Open Lower; U.S. Adds 273,000 Jobs For February
Mar 6 InVivo down 56% after pricing equity offering
Mar 6 InVivo Therapeutics Announces Pricing of $7.0 Million Public Offering
Mar 2 140 Biggest Movers From Friday
Feb 28 140 Biggest Movers From Yesterday
Feb 18 Bellerophon Therapeutics leads healthcare gainers; ImmunoGen among losers
Feb 12 52 Stocks Moving In Wednesday's Mid-Day Session
Feb 3 InVivo to reverse split shares 1:30
Feb 3 InVivo Therapeutics Announces Reverse Stock Split
Jan 29 43 Healthcare Stocks Moving In Tuesday's After-Market Session
Jan 8 50 Healthcare Stocks Moving In Wednesday's Pre-Market Session

Back to the Main NVIV Page...